FDA Clearance Tracker · P120023-S005
KAMRA INLAY
Last checked: Nov 20, 2026Latest source record: Jul 18, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jul 18, 2017
Approved
Time to decision
174 days
Received Jan 25, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
Device type
- Device type
- Implant, corneal, refractive (LQE)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for revisions to the labeling to include the results of the post-approval study.
Source documents
Other decisions for Corneagen
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EndoSerter-PL510(k)
K203586 · Decided Feb 2, 2022 · 421 days after receipt
Device type: Graft Insertion Instrument For Endothelial Keratoplasty (OTZ) · Ophthalmology
- KAMRA INLAYPMA
P120023 · Decided Apr 17, 2015 · 856 days after receipt
Device type: Implant, corneal, refractive (LQE) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.